DBVT

DBV TECHNOLOGIES S A

DBVT·23306J309·US·ADR·Healthcare - Biotechnology-Activist

DBVT (DBV TECHNOLOGIES S A) is held by 34 institutional investors as of Q1 2026. Largest holders: Artisan Partners Limited Partnership ($46.4M), BAKER BROS. ADVISORS LP ($30.5M), Duquesne Family Office LLC ($8M). Net institutional sentiment: Mixed.

34
Holders
Avg rating(12 Elite)
$120.8M
Total Value
55% (39)
Fund Consensus
18 buying - 15 selling
DBVTSmart Money Verdict
View all
Held by 34 funds
12 elite
Who's Trading
ActivistMBMPM BioImpact LLC8.8%May 15, 2026
ActivistADAdage Capital Management, L.P.7.3%May 13, 2026
ActivistVOVivo Opportunity Fund Holdings, L.P.4.0%May 12, 2026
ActivistRDRaymond Debbane6.5%May 5, 2026
ActivistCitadel Advisors LLCCitadel Advisors LLC3.1%Feb 17, 2026
InsiderEBEPIC BpifranceSell $5.4MDec 18, 2025
InsiderEBEPIC BpifranceSell $9.9MDec 17, 2025
InsiderEBEPIC BpifranceSell $211KDec 17, 2025
InsiderMPMohideen PharisSell $4KNov 21, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
2.2M(-32.9%)$46.4M0.1%-13.45%
0
Unchanged
1.5M$30.5M0.2%+423.49%
0
New
383,363$8M0.2%-24.60%
45
Decreased
318,959(-50.2%)$6.7M0.0%+19.56%
0
Decreased
233,429(-0.7%)$4.9M0.0%-14.16%
0
New
231,417$4.8M0.0%-24.60%
37
Decreased
168,180(-24.6%)$3.5M0.0%-13.46%
0
Increased
146,116(+19.3%)$3.1M0.0%-11.86%
31
New
128,560$2.7M0.0%-24.60%
36
Increased
95,714(+327.4%)$2M0.0%-22.39%
42
Decreased
79,537(-67.5%)$1.7M0.0%-14.12%
0
New
55,871$1.2M0.0%-24.60%
35
New
42,055$878,5290.0%-24.60%
34
Increased
37,427(+172.5%)$781,8500.0%-21.08%
40
Increased
33,040(+32.2%)$690,2050.0%-16.96%
31
New
30,736$642,0760.0%-24.60%
34
Increased
25,358(+93.3%)$529,7290.0%-19.54%
38
Decreased
19,047(-60.1%)$397,8920.0%-2.61%
0
Decreased
16,764(-74.7%)$350,2000.0%-14.16%
0
Decreased
11,538(-57.6%)$241,0290.0%-14.16%
0

Showing 1-20 of 39

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used